On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
71° Feels Like: 71°
Wind: ESE 12 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Cloudy 73°

Tonight

Thunderstorms 63°

Tomorrow

Scattered Thunderstorms 84°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

UCB says had positive trial for Vimpat as monotherapy

BRUSSELS (Reuters) - Belgian pharmaceutical company UCB said on Tuesday its new epilepsy treatment Vimpat had produced promising results in a Phase III trial into its use without other drugs.

UCB said it would to submit the data as part of a supplementary new drug application for lacosamide, marketed as Vimpat, to the U.S. Food and Drug Administration. The application is planned in the second half of 2013.

Vimpat is approved as an adjunctive therapy for the treatment of partial-onset seizures in adults with epilepsy, but not as a monotherapy.

(Reporting by Philip Blenkinsop)

Comments